13.79  0.33 (2.45%)		11-07 16:00
Open: 13.52 High: 13.925 Volume: 355,274		Pre. Close: 13.46 Low: 13.52 Market Cap: 807(M)

Short term
Mid term
Targets	6-month :	16.42	1-year :	17.16
Resists	First :	14.06	Second :	14.69
Pivot price	13.85
Supports	First :	13.02	Second :	10.84
MAs	MA(5) :	13.6	MA(20) :	13.79
	MA(100) :	12.75	MA(250) :	14.05
MACD	MACD :	-0.2	Signal :	-0.1
%K %D	K(14,3) :	44.2	D(3) :	40
RSI	RSI(14): 49.3
52-week	High :	21.47	Low :	9.19

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ EMBC ] has closed above bottom band by 44.9%. Bollinger Bands are 38.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	13.94 - 14	14 - 14.04
Low:	13.37 - 13.44	13.44 - 13.49
Close:	13.67 - 13.78	13.78 - 13.88

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

Sat, 01 Nov 2025
Is Now The Time To Look At Buying Embecta Corp. (NASDAQ:EMBC)? - Sahm

Fri, 31 Oct 2025
Is Embecta Corp. (NASDAQ:EMBC) Potentially Undervalued? - Yahoo Finance

Sun, 31 Aug 2025
Upgrading Embecta Due To Reorganization And Growth Initiatives (NASDAQ:EMBC) - Seeking Alpha

Thu, 28 Aug 2025
Even With A 29% Surge, Cautious Investors Are Not Rewarding Embecta Corp.'s (NASDAQ:EMBC) Performance Completely - simplywall.st

Tue, 26 Aug 2025
embecta to Participate in Investor Events - GlobeNewswire

Tue, 12 Aug 2025
Embecta Corp. (NASDAQ:EMBC) Q3 2025 Earnings Call Transcript - Insider Monkey

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares Out	58 (M)
Shares Float	57 (M)
Held by Insiders	0.4 (%)
Held by Institutions	102 (%)
Shares Short	2,810 (K)
Shares Short P.Month	2,630 (K)

EPS	1.41
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-11.45
Profit Margin	7.5 %
Operating Margin	35.4 %
Return on Assets (ttm)	3.7 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	8.3 %
Gross Profit (p.s.)	11.94
Sales Per Share	18.8
EBITDA (p.s.)	1.89
Qtrly Earnings Growth	211.1 %
Operating Cash Flow	134 (M)
Levered Free Cash Flow	11 (M)

PE Ratio	9.71
PEG Ratio	0
Price to Book value	-1.21
Price to Sales	0.73
Price to Cash Flow	6

Dividend	0.15
Forward Dividend	0
Dividend Yield	1%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.